David Adlam

Showing 1-3 of 3 articles

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Long-term follow-up of spontaneous coronary artery dissection treated with bioresorbable scaffolds

Macaya F, Salinas P, Gonzalo N, Camacho-Freire SJ, Jackson R, Massot M, Ortas-Nadal MR, Sanchez Recalde A, Diaz-Fernandez J, Moreu J, Adlam D, Escaned J

January 18, 2019 | 10.4244/EIJ-D-18-00519

Editorial on: “Characteristics of extension and de novo recurrent spontaneous coronary artery dissection”

Adlam D, Wood A, Al-Hussaini A

December 8, 2017 | 10.4244/EIJV13I12A220

1

Latest news

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

Ahead of print: EAPCI Core Curriculum for PCI (2020)

IVUS guidance during left main PCI: not if, but when and how

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

Left main PCI: are we giving the kiss the attention it deserves?

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke